Project ECHO aims to boost provider self-efficacy while lowering costs, explained Mark Lovgren, director of Telehealth Services at Oregon Health and Science University. He hopes the program will expand to cover additional chronic conditions in the future.
Project ECHO aims to boost provider self-efficacy while lowering costs, explained Mark Lovgren, director of Telehealth Services at Oregon Health and Science University. He hopes the program will expand to cover additional chronic conditions in the future.
Transcript
How does Project ECHO help advance the Triple Aim?
Everything we do in telehealth, we’re always thinking about, what benefit are we going to provide to somebody? Is this going to be increased patient access for our patients? Is this going to help lower our costs? Things for ECHO that we look at is we measure provider self-efficacy — do they feel like after they go through ECHO, that they become more comfortable managing patients with psychiatric medication management as a component of their treatment. We also … hope to see a decrease in the emergency department visits, a decrease in pharmacological spend, and a decrease in hospitalizations. I think it’s too early right now with our first foray into ECHO to be able to say definitively we’ve been able to move those levers, but we hope within the next year or two we’ll be able to do that.
How would you like to see Project ECHO evolve? What is the next stage?
I think in our partnership with HealthShare, we’ve actually brought on a second CCO to help fund us for our second year of ECHO. And we hope that ECHO will be something that the state will support, the state of Oregon, whether it’s through CCOs participating and supporting financially ECHO. We also would like to run ECHO in other clinical areas. Other … Project ECHOs that happen across the country and the world deal with things like Hep C, diabetes, rheumatology, other chronic conditions. So that’s where we see both an expansion in chronic conditions that we cover in ECHO, as well as looking for new models to sustain it.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More